Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells

被引:0
作者
Sanjeev Kumar
Christopher S Bryant
Sreedhar Chamala
Aamer Qazi
Shelly Seward
Jagannath Pal
Christopher P Steffes
Donald W Weaver
Robert Morris
John M Malone
Masood A Shammas
Madhu Prasad
Ramesh B Batchu
机构
[1] Wayne State University,Laboratory of Surgical Oncology & Developmental Therapeutics, Department of Surgery
[2] Wayne State University,Dept of Ob/Gyn
[3] Karmanos Cancer Institute,undefined
来源
Molecular Cancer | / 8卷
关键词
Human Immunodeficiency Virus; Ovarian Cancer; Ovarian Cancer Cell; Ritonavir; Ovarian Cancer Cell Line;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 185 条
[21]  
Carlei D(2007)Nelfinavir, A lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo Clinical Cancer Research 13 5183-1896
[22]  
Barillari G(2005)HIV protease inhibitors block Akt signaling and radiosensitize tumor cells both in vitro and in vivo Cancer Research 65 8256-1014
[23]  
Ensoli B(2006)Effects of HIV protease inhibitor ritonavir on Akt-regulated cell proliferation in breast cancer Clinical Cancer Research 12 1883-874
[24]  
Clifford GM(2005)Finding new tricks for old drugs: an efficient route for public-sector drug discovery Nature Reviews Drug Discovery 4 1005-1187
[25]  
Polesel J(2008)Lenalidomide and its role in the management of multiple myeloma Expert Review of Anticancer Therapy 8 865-81
[26]  
Rickenbach M(2003)Thiazolidinediones – some recent developments Expert Opinion on Investigational Drugs 12 1179-135
[27]  
Dal Maso L(2008)Nonimmunosuppressive effects of mammalian target of rapamycin inhibitors Transplantation Reviews 22 73-1299
[28]  
Keiser O(2000)Medroxyprogesterone acetate and cancer cachexia: interleukin-6 involvement Breast Cancer 7 130-516
[29]  
Kofler A(2006)Lopinavir/ritonavir: a review of its use in the management of HIV infection Drugs 66 1275-269
[30]  
Rapiti E(2003)Ovarian cancer: strategies for overcoming resistance to chemotherapy Nature Reviews Cancer 3 502-3695